Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Antithymocyte Globulin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT02267512
What this trial is testing

Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients

Who this might be right for
De Novo Kidney Transplant Patients
Astellas Pharma Inc 280
Testing effectiveness (Phase 2)Study completedNCT00038831
What this trial is testing

Allo Transplantation With Mylotarg, Fludarabine and Melphalan for AML, CML and MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic SyndromeChronic Lymphocytic Leukemia
M.D. Anderson Cancer Center 47
Testing effectiveness (Phase 2)Study completedNCT02441803
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation (AlloSCT) Initial Salvage Therapy for Induction Failure Acute Myeloid Leukemia (AML)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 11
Large-scale testing (Phase 3)Study completedNCT00000597
What this trial is testing

Multi-Center Trial of Anti-Thymocyte Globulin in Treatment of Aplastic Anemia and Other Hematologic Disorders

Who this might be right for
Anemia, AplasticHematologic DiseasesPancytopenia+1 more
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Study completedNCT03734601
What this trial is testing

Total Body Irradiation +/- Total Lymphoid Irradiation & Anti-Thymocyte Globulin in Non-myeloablative Hematopoietic Cell Transplantation

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic SyndromesMyeloproliferative Disorder+6 more
Stanford University 22
Testing effectiveness (Phase 2)Ended earlyNCT00635024
What this trial is testing

Anti-thymocyte Globulin and Melphalan in Treating Patients With Relapsed Multiple Myeloma

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Mayo Clinic 1
Not applicableUnknownNCT00093587
What this trial is testing

Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia

Who this might be right for
Graft Versus Host DiseaseLeukemia
Jonsson Comprehensive Cancer Center
Testing effectiveness (Phase 2)Study completedNCT00611351
What this trial is testing

Busulfan, Cyclophosphamide, & Antithymocyte Globulin Followed by Stem Cell Transplant in Treating Hematologic Cancer

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+4 more
University of Nebraska 5
Not applicableStudy completedNCT00859131
What this trial is testing

Safety and Efficacy Study of Thymoglobulin Versus IL2 Receptor Antagonists

Who this might be right for
End Stage Renal Disease
Medical University of South Carolina 200
Testing effectiveness (Phase 2)Study completedNCT00886522
What this trial is testing

Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies

Who this might be right for
Hematological Malignancies
IRCCS Azienda Ospedaliero-Universitaria di Bologna 23
Testing effectiveness (Phase 2)Study completedNCT02404025
What this trial is testing

Eltrombopag in Combination With Rabbit Anti-thymocyte Globulin/Cyclosporine A in Naive Aplastic Anemia (AA) Subjects

Who this might be right for
Aplastic Anemia
Novartis Pharmaceuticals 10
Very early researchEnded earlyNCT01318915
What this trial is testing

Research Study of ATG and Rituximab in Renal Transplantation

Who this might be right for
Renal Transplant Recipients
National Institute of Allergy and Infectious Diseases (NIAID) 10
Testing effectiveness (Phase 2)Study completedNCT00732316
What this trial is testing

Donor Stem Cell Transplant After Busulfan, Fludarabine, and Antithymocyte Globulin in Treating Patients With Hematologic Cancer or Myelodysplastic Syndrome

Who this might be right for
LeukemiaMyelodysplastic Syndromes
Asan Medical Center 54
Post-approval studies (Phase 4)Study completedNCT03468478
What this trial is testing

Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation

Who this might be right for
Kidney Transplant Infection
Hospital do Rim e Hipertensão 1,209
Testing effectiveness (Phase 2)Study completedNCT00076570
What this trial is testing

Combination Drug Therapy Followed by Single Drug Steroid Free Therapy to Prevent Organ Rejection in Kidney Transplantation

Who this might be right for
Kidney Transplantation
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 31
Testing effectiveness (Phase 2)UnknownNCT03357159
What this trial is testing

Anti T-lymphocyte Immunoglobulin With Post Transplant Cyclophosphamide to Prevent GVHD Post Allogeneic Transplantation

Who this might be right for
Graft Versus Host Disease
Sheba Medical Center 30
Not applicableUnknownNCT01255319
What this trial is testing

Cyclophosphamide, Fludarabine and Antithymocyte Globulin Conditioning in Myelodysplastic Syndrome (MDS)

Who this might be right for
Myelodysplastic Syndrome
Cooperative Study Group A for Hematology 15
Testing effectiveness (Phase 2)Study completedNCT00802568
What this trial is testing

Fludarabine, Busulfan, Antithymocyte Globulin, and Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma That Has Not Responded to Treatment

Who this might be right for
Multiple Myeloma and Plasma Cell Neoplasm
Institut Paoli-Calmettes 48
Testing effectiveness (Phase 2)UnknownNCT01810926
What this trial is testing

T&B Depletion Non Malignant

Who this might be right for
Graft Versus Host Disease
Franco Locatelli 130
Testing effectiveness (Phase 2)Ended earlyNCT00523809
What this trial is testing

Allogeneic Hematopoietic Stem Cell Transplantation With Bevacizumab for Advanced Solid Tumor

Who this might be right for
Breast CancerOvarian Cancer
M.D. Anderson Cancer Center 5
Next Page